Insider Buying in Clovis Oncology, Inc. (CLVS)

On August 20, 2019, James Blair – Director of Clovis Oncology, Inc. (CLVS) – purchased 20,000 shares of CLVS at $5.97. His out of pocket cost was $119,400.